Panagora Asset Management’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Panagora Asset Management’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-7,394	Closed	-$111K	–	2533
2016 Q2	$111K	Buy	+7,394	New	+$95K	﹤0.01%	1884
2016 Q1	–	Sell	-802	Closed	-$13K	–	2390
2015 Q4	$13K	Sell	802 -2,895	-78%	-$45.6K	﹤0.01%	2202
2015 Q3	$57K	Sell	3,697 -159	-4%	-$3.44K	﹤0.01%	1963
2015 Q2	$94K	Hold	3,856	–	–	﹤0.01%	1965
2015 Q1	$90K	Buy	3,856 +2,360	+158%	+$62.5K	﹤0.01%	1962
2014 Q4	$38K	Hold	1,496	–	–	﹤0.01%	2094
2014 Q3	$47K	Sell	1,496 -580	-28%	-$15.7K	﹤0.01%	2039
2014 Q2	$54K	Hold	2,076	–	–	﹤0.01%	2078
2014 Q1	$49K	Hold	2,076	–	–	﹤0.01%	2095
2013 Q4	$53K	Buy	2,076 +776	+60%	+$17.5K	﹤0.01%	1972
2013 Q3	$27K	Buy	+1,300	New	+$28.9K	﹤0.01%	2145

Panagora Asset Management's SGNT Position: Q3 2016 in Review

Panagora Asset Management sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 7,394 shares — an estimated $111K sold.

Panagora Asset Management first reported a position in SGNT in Q3 2013 and held it in 11 quarters. The position peaked at $111K in Q2 2016. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

Panagora Asset Management reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
Panagora Asset Management sold 7,394 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $111K.
Panagora Asset Management first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2013 and held it in 11 quarters.
Panagora Asset Management's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $111K in Q2 2016.
0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Panagora Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.